Liquidia (LQDA) Other Non-Current Assets (2019 - 2026)

Liquidia's (LQDA) quarterly Other Non-Current Assets came in at $3.5 million in Q1 2026, down 77.45% year-on-year from $15.5 million in Q1 2025, and little changed quarter-over-quarter from $3.5 million in Q4 2025.

Liquidia (LQDA) Other Non-Current Assets (2019 - 2026) Analysis & Trends

Liquidia's Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $3.5 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets fell 77.45% year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was $3.5 million, a 77.45% decrease from a year earlier, with the FY2025 full-year figure at $3.5 million, down 67.91% from the prior year.
  • Other Non-Current Assets held at $3.5 million in Q1 2026 per LQDA's latest filing, from $3.5 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $15.5 million in Q1 2025 and bottomed at $224000.0 in Q1 2024.
  • The 5-year median for Other Non-Current Assets is $307000.0 (2022), against an average of $3.0 million.
  • Across the five-year window, Other Non-Current Assets jumped 6838.39% in 2025 and sank 77.45% in 2026, its largest moves.
  • Year by year, Other Non-Current Assets stood at $307000.0 in 2022, then declined by 6.51% to $287000.0 in 2023, then surged by 3704.18% to $10.9 million in 2024, then plunged by 67.91% to $3.5 million in 2025, then changed by 0.0% to $3.5 million in 2026.
  • Per Business Quant, the three latest LQDA Other Non-Current Assets figures stand at $3.5 million (Q1 2026), $3.5 million (Q4 2025), and $3.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Liquidia 7.84 Bn 7.61 Bn 121.79 Mn 3.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.50 Mn
Dec 31, 2025 3.50 Mn
Sep 30, 2025 3.50 Mn
Jun 30, 2025 3.50 Mn
Mar 31, 2025 15.54 Mn
Dec 31, 2024 10.92 Mn
Sep 30, 2024 7.76 Mn
Jun 30, 2024 224,000.00
Mar 31, 2024 224,000.00
Dec 31, 2023 287,000.00
Sep 30, 2023 287,000.00
Jun 30, 2023 260,000.00
Mar 31, 2023 307,000.00
Dec 31, 2022 307,000.00
Sep 30, 2022 307,000.00
Jun 30, 2022 307,000.00
Mar 31, 2022 307,000.00
Dec 31, 2021 311,000.00
Sep 30, 2021 312,925.00
Jun 30, 2021 318,331.00